Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7
1984
Effects of Tamoxifen on Breast Cancer Cells
Sample size: 3
publication
Evidence: moderate
Author Information
Author(s): A.E. Lykkesfeldt, J.K. Larsen, I.J. Christensen, P. Briand
Primary Institution: The Fibiger Laboratory, The Finsen Laboratory
Hypothesis
Does tamoxifen affect the cell cycle kinetics of MCF-7 breast cancer cells?
Conclusion
Tamoxifen inhibits the growth of MCF-7 cells by arresting them in the G1 and G2 phases of the cell cycle.
Supporting Evidence
- Tamoxifen treatment led to an increase in the proportion of cells in the G1 phase of the cell cycle.
- Cells treated with tamoxifen showed a dramatic decrease in the growth fraction.
- Tamoxifen's growth inhibitory effect can be reversed by the addition of oestradiol.
Takeaway
Tamoxifen is a medicine that helps treat breast cancer by stopping cancer cells from growing.
Methodology
MCF-7 cells were treated with tamoxifen and analyzed using flow cytometry to assess cell cycle phases.
Limitations
The study only examined one cell line and the effects of a specific concentration of tamoxifen.
Participant Demographics
Human breast cancer cell line MCF-7.
Want to read the original?
Access the complete publication on the publisher's website